HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yingying Xu Selected Research

Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

1/2023Changes in Serum Concentrations of Vascular Endothelial Growth Factors-A and B after Intravitreal Injection of Ranibizumab and Conbercept for Retinopathy of Prematurity.
2/2021Vascular endothelial growth factor alleviates mitochondrial dysfunction and suppression of mitochondrial biogenesis in models of Alzheimer's disease.
3/2013Positive association of the vascular endothelial growth factor-A +405 GG genotype and poor survival in stage I-II gastric cancer in the Northern Chinese population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yingying Xu Research Topics

Disease

69Neoplasms (Cancer)
01/2024 - 07/2009
37Breast Neoplasms (Breast Cancer)
03/2024 - 10/2011
15Neoplasm Metastasis (Metastasis)
10/2022 - 01/2011
10Stomach Neoplasms (Stomach Cancer)
05/2022 - 07/2009
7Carcinogenesis
03/2024 - 09/2012
7Inflammation (Inflammations)
02/2024 - 08/2019
6Hepatocellular Carcinoma (Hepatoma)
05/2024 - 10/2011
6Colorectal Neoplasms (Colorectal Cancer)
12/2023 - 06/2010
6Triple Negative Breast Neoplasms
01/2023 - 01/2018
5Type 2 Diabetes Mellitus (MODY)
06/2023 - 01/2020
5Alzheimer Disease (Alzheimer's Disease)
11/2021 - 11/2019
4Atherosclerosis
02/2024 - 01/2023
4Wounds and Injuries (Trauma)
02/2024 - 04/2011
4Pancreatic Neoplasms (Pancreatic Cancer)
05/2022 - 09/2019
4Esophageal Neoplasms (Esophageal Cancer)
01/2022 - 02/2017
4Pain (Aches)
01/2022 - 05/2016
3Liver Diseases (Liver Disease)
05/2024 - 01/2021
3Obesity
03/2024 - 05/2016
3Cardiovascular Diseases (Cardiovascular Disease)
02/2024 - 01/2020
3Asthma (Bronchial Asthma)
02/2024 - 02/2010
3Insulin Resistance
02/2024 - 03/2021
3Infections
02/2024 - 01/2017
3Cognitive Dysfunction
01/2024 - 01/2019
3Liver Neoplasms (Liver Cancer)
09/2023 - 01/2021
3Fibrosis (Cirrhosis)
09/2023 - 01/2021
3Glioma (Gliomas)
01/2023 - 01/2022
3Cockayne Syndrome (Syndrome, Cockayne)
01/2023 - 10/2019
3Hyperthermia
01/2021 - 05/2014
3Stroke (Strokes)
01/2020 - 01/2018
2Hypoxia (Hypoxemia)
01/2024 - 01/2021
2Frailty
11/2023 - 02/2023
2Periodontitis
10/2023 - 12/2020
2Metabolic Syndrome (Dysmetabolic Syndrome X)
06/2023 - 01/2020
2Necrosis
01/2023 - 08/2020
2Premature Birth (Birth, Premature)
01/2023 - 01/2021
2COVID-19
01/2023 - 01/2021
2Carcinoma (Carcinomatosis)
01/2022 - 08/2012
2Lymphatic Metastasis
01/2022 - 12/2013
2Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
01/2022 - 09/2021

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
01/2023 - 07/2009
14Biomarkers (Surrogate Marker)IBA
12/2023 - 09/2012
8Estrogen ReceptorsIBA
04/2023 - 03/2012
6Glucose (Dextrose)FDA LinkGeneric
02/2024 - 01/2020
6AntigensIBA
01/2022 - 03/2012
5LipidsIBA
02/2024 - 08/2010
5Therapeutic UsesIBA
02/2024 - 01/2020
5Messenger RNA (mRNA)IBA
12/2023 - 12/2017
5CytokinesIBA
10/2023 - 08/2019
5Indicators and Reagents (Reagents)IBA
09/2022 - 11/2017
5Long Noncoding RNAIBA
06/2022 - 03/2020
5CD13 Antigens (Alanine Aminopeptidase)IBA
08/2013 - 01/2011
4Type A Botulinum Toxins (Botox)FDA Link
01/2024 - 07/2015
4Reactive Oxygen Species (Oxygen Radicals)IBA
10/2023 - 01/2018
4RNA (Ribonucleic Acid)IBA
12/2021 - 07/2012
3Phenobarbital (Luminal)FDA Link
03/2024 - 01/2021
3IonsIBA
01/2024 - 10/2021
3Hormones (Hormone)IBA
01/2024 - 01/2020
3Progesterone Receptors (Progesterone Receptor)IBA
04/2023 - 01/2018
3Epidermal Growth Factor (EGF)IBA
04/2023 - 01/2020
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 03/2013
3EnzymesIBA
05/2022 - 07/2016
3Superoxide DismutaseIBA
10/2021 - 06/2016
3HydrogelsIBA
03/2021 - 11/2019
3Vitamin DFDA LinkGeneric
01/2021 - 12/2020
3MicroRNAs (MicroRNA)IBA
01/2021 - 09/2012
3Formaldehyde (Formol)FDA Link
01/2018 - 03/2012
3ParaffinIBA
01/2018 - 03/2012
3Cyclin D1IBA
12/2012 - 07/2009
2Fatty Acids (Saturated Fatty Acids)IBA
05/2024 - 03/2021
2hydroxide ionIBA
03/2024 - 12/2020
2HomocysteineIBA
02/2024 - 08/2019
2Asialoglycoprotein ReceptorIBA
02/2024 - 10/2021
21-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2024 - 09/2020
2VaccinesIBA
12/2023 - 01/2023
2Hypoglycemic Agents (Hypoglycemics)IBA
11/2023 - 01/2021
2PlatinumIBA
11/2023 - 01/2022
2phthalic acid (phthalate)IBA
10/2023 - 05/2016
2Insulin (Novolin)FDA Link
06/2023 - 12/2022
2Triglycerides (Triacylglycerol)IBA
06/2023 - 01/2021
2oxidized low density lipoproteinIBA
06/2023 - 12/2021
2CholesterolIBA
06/2023 - 03/2020
2HDL CholesterolIBA
06/2023 - 10/2021
2Caspase 3 (Caspase-3)IBA
06/2023 - 10/2011
2SincalideFDA Link
05/2023 - 01/2020
2N-acetyltalosaminuronic acid (NAT)IBA
04/2023 - 01/2023
2Chondroitin Sulfates (Chondroitin Sulfate)IBA
12/2022 - 06/2021
2Heparin (Liquaemin)FDA LinkGeneric
12/2022 - 07/2009
2Small Interfering RNA (siRNA)IBA
05/2022 - 09/2012
2Paclitaxel (Taxol)FDA LinkGeneric
02/2022 - 10/2013
2GastrinsIBA
01/2022 - 09/2012
2LipopolysaccharidesIBA
01/2022 - 08/2019

Therapy/Procedure

27Therapeutics
03/2024 - 10/2011
9Neoadjuvant Therapy
04/2023 - 12/2019
8Drug Therapy (Chemotherapy)
11/2023 - 06/2012
6Radiotherapy
01/2022 - 05/2014
4Hepatectomy
02/2024 - 08/2022
4Gastrectomy
01/2022 - 11/2012
2Adjuvant Chemotherapy
03/2024 - 01/2020
2Photochemotherapy (Photodynamic Therapy)
01/2024 - 09/2020
2Communication Aids for Disabled (TDD)
11/2023 - 01/2023